Genomic Health (GHDX) to Present Additional Oncotype DX Data at ASCO 2016
Tweet Send to a Friend
Genomic Health, Inc. (Nasdaq: GHDX) announced that the company will present results from seven Oncotype DX® studies at the 2016 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
